BRIEF-Merck research chief says company aims for big share of hepatitis C market

June 12 Thu Jun 12, 2014 11:38am EDT

June 12 (Reuters) - Merck & Co Inc : * Research chief, speaking at Goldman Sachs healthcare conference, says Merck would be open to big acquisition for biotech

products, not for technology platform * Research chief says company aims to capture "substantial" part of hepatitis c

market by selling best drugs at "fair cost proposition"

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.